The Legacy of Edwards and Steptoe and the Windy Roads of Assisted Reproduction: Where Do We Stand with Venous Thromboembolism?

Elvira Grandone; Walter Ageno

doi:10.1055/a-1996-1341

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2023; 123(03): 267-269
DOI: 10.1055/a-1996-1341

Invited Editorial Focus

The Legacy of Edwards and Steptoe and the Windy Roads of Assisted Reproduction: Where Do We Stand with Venous Thromboembolism?

Autor*innen

Elvira Grandone

¹Department of Obstetrics and Gynecology, University of Foggia, Foggia, Italy

²Thrombosis and Haemostasis Unit, Fondazione IRCCS “Casa Sollievo della Sofferenza,” Foggia, Italy
Walter Ageno

³Department of Medicine and Surgery, University of Insubria, Varese, Italy

Abstract

Volltext

Referenzen

References
1 Grandone E, Di Micco PP, Villani M. et al; RIETE Investigators. Venous thromboembolism in women undergoing assisted reproductive technologies: data from the RIETE Registry. Thromb Haemost 2018; 118 (11) 1962-1968
2 Centers for Disease Control and Prevention. 2010 Assisted Reproductive Technology: National Summary Report. Atlanta, Georgia: Society for Assisted Reproductive Technologies; 2012
3 ItOSS. Maternal mortality surveillance. Accessed December 27, 2022 at: https://www.epicentro.iss.it/en/itoss/maternal-mortality-surveillance
4 Goaulou M, Noumegni S, de Moreuil C. et al. Venous thromboembolism associated with assisted reproductive technology: a systematic review and meta-analysis. Thromb Haemost 2023; 123 (03) 291-302
5 Olausson N, Discacciati A, Nyman AI. et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilization with fresh respectively frozen-thawed embryo transfer: Nationwide cohort study. J Thromb Haemost 2020; 18 (08) 1965-1973
6 Westerlund E, Antovic A, Hovatta O. et al. Changes in von Willebrand factor and ADAMTS13 during IVF. Blood Coagul Fibrinolysis 2011; 22 (02) 127-131
7 Keiser UB. The pathogenesis of ovarian hyperstimulation syndrome. N Engl J Med 2003; 349: 729-732
8 Sennström M, Rova K, Hellgren M. et al. Thromboembolism and in vitro fertilization - a systematic review. Acta Obstet Gynecol Scand 2017; 96 (09) 1045-1052
9 Francés-Herrero E, Lopez R, Hellström M. et al. Bioengineering trends in female reproduction: a systematic review. Hum Reprod Update 2022; 28 (06) 798-837
10 Chan WS. The ‘ART’ of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol 2009; 21 (03) 207-218
11 Villani M, Dentali F, Colaizzo D. et al. Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort. BMJ Open 2015; 5 (10) e008213
12 Wang J, Tan JS, Hua L, Sheng Q, Huang X, Liu P. Genetic predisposition of both waist circumference and hip circumference increased the risk of venous thromboembolism. Thromb Haemost 2023; 123 (03) 355-369
13 Noumegni SR, Mansourati V, Tromeur C. et al. Risk factors of cardiovascular death after venous thromboembolism: results from a prospective cohort study. Thromb Haemost 2022; 122 (10) 1744-1756
14 Zhang YJ, Li ZH, Shen D. et al. Association of combined lifestyle and polygenetic risk with incidence of venous thromboembolism: a large population-based cohort study. Thromb Haemost 2022; 122 (09) 1549-1557
15 D'Apolito M, Ariano A, D'Andrea G. et al. Identification of the novel G250R variant indicates a role for thrombomodulin in modulating the risk for venous thromboembolism. Thromb Haemost 2022; 122 (10) 1827-1832
16 Roy DC, Wang TF, Mallick R. et al. Growth differentiation factor-15, high-sensitivity cardiac troponin T, and N-terminal pro-B-type natriuretic peptide for predicting risk of venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Haemost 2022; 122 (07) 1169-1176
17 Florin J, Stalder O, Baumgartner C, Méan M, Rodondi N, Aujesky D. Do patients with a family or personal history of venous thromboembolism have an increased risk of recurrence?. Thromb Haemost 2022; 122 (06) 1017-1026
18 Rothberg MB, Hamilton AC, Greene MT. et al. Derivation and validation of a risk factor model to identify medical inpatients at risk for venous thromboembolism. Thromb Haemost 2022; 122 (07) 1231-1238
19 Evensen LH, Arnesen CAL, Rosendaal FR. et al. The risk of venous thromboembolism attributed to established prothrombotic genotypes. Thromb Haemost 2022; 122 (07) 1221-1230
20 Noumegni SR, Hoffmann C, Tromeur C. et al. Risk factors of arterial events in patients with venous thromboembolism: a systematic review and meta-analysis. Thromb Haemost 2022; 122 (04) 590-599
21 Olausson N, Mobarrez F, Wallen H, Westerlund E, Hovatta O, Henriksson P. Microparticles reveal cell activation during IVF - a possible early marker of a prothrombotic state during the first trimester. Thromb Haemost 2016; 116 (03) 517-523
22 Michalas S, Loutradis D, Drakakis P. et al. Oocyte donation to women over 40 years of age: pregnancy complications. Eur J Obstet Gynecol Reprod Biol 1996; 64 (02) 175-178
23 Gris JC, Bourguignon C, Bouvier S. et al. Pregnancy after combined oral contraceptive-associated venous thromboembolism: an international retrospective study of outcomes. Thromb Haemost 2022; 122 (10) 1779-1793